Technology, Innovation & Science

The Perth biotech company has welcomed a US academic for a series of talks at universities across the country.

A cohort chosen from 83 applications will get a shot at a slice of more than $700,000 in investment funds.

Robotic technology company FBR has looked to the Northern Territory in its bid to advance sales of its Hadrian X building and construction units.

The Auditor General’s report on the state’s major IT projects found the information given to the public to be patchy and inconsistent, including a $1.6 billion cost discrepancy.

High Wycombe-based FBR has filed documents to secure an engineering service agreement with Samsung Heavy Industries.

Amazon said it would provide billions in funding over the next five years to expand Australian data centres and renewables projects.

Perth-based neurological drug developer Argenica Therapeutics has been knocked back by the US Food and Drug Administration, dashing hopes its US clinical trials would soon start.

Escalante-backed icetana AI has inked a partnership deal with leading global tech company SoftBank Robotics, as it gears up to enter Japan.

West Leederville medtech company VeinTech is set to expand its footprint in the United States after being awarded more than $1 million in funding.

OPINION: The creators of ChatGPT just spent billions betting coders will still exist in the future.

WA’s first AI startup incubator successfully featured 14 youth founders exploiting the latest technologies.

The state government has awarded a tender to more than a dozen companies which will receive about $375 million worth of technology infrastructure work.

ANALYSIS: Women in startups are notoriously underfunded, yet are as successful, if not more so, than men. We profile three in WA.

Science and Technology Australia president Sharath Sriram has been named WA’s new chief scientist, taking the helm from Peter Klinken.

Nedlands-based Nanollose has appointed Andrew Moullin as its managing director and chief executive, effective from July 14.

The Legal Practice Board of WA has become the latest target of a cyber attack, after hackers accessed bank details and other information of legal professionals.

A local cybersecurity and privacy partner has warned businesses not to ‘recklessly delay’ investing in protecting their data following several cyberattacks in Perth.

OPINION: AI presents a transformative opportunity for forward-thinking, established SMEs planning to scale.

Two tech and data friends have launched a site to help people with complaints against banks.

Curtin University researchers have found a new way to upgrade iron ore for green steel production – all while using desalination waste.

Perth software companies INX Software and K2fly have completed their merger, rebranding as Quartex while also committing to remaining headquartered in Perth.

The state government has committed more than $70 million towards medical research, including allocating $25 million among 20 WA institutions.

OPINION: A framework detailed in 2017 is just as valid today in terms of automation in the workplace.

OPINION: AI is causing an unexpected shift towards authenticity, community and exclusivity online.

Murdoch-based Orthocell’s push to expand the reach of its nerve repair product Remplir has continued, following news it has received regulatory approval in Hong Kong.

The robotic tech company raised $6.3 million amid efforts to cut operational costs by 70 per cent.

Orthocell boss Paul Anderson said the Murdoch-based biotech medical company is “well ahead” of its original targets in relation to US sales of its nerve repair product, Remplir.

Two former stockbrokers are planning an ASX listing for their drone business next financial year.

FBR shareholders have overwhelmingly endorsed all three resolutions at the company’s extraordinary general meeting on Tuesday, following a late push to have it deferred.

DUG Technology managing director Matthew Lamont is excited by the company’s future, as it continues to move forward with its elastic MP-FWI imaging technology.

Shares in Murdoch-based Orthocell rose by 15 per cent early on Wednesday, following news the biotech medical company had received regulatory approval to sell its nerve repair product in Canada.

Fresh from receiving clearance from the Food and Drug Administration to distribute its nerve repair product Remplir in the US earlier this month, Murdoch-based Orthocell has appointed an initial four distributors.